| | ||||||||||
| 1 | INN | Class | Route (list) | PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that the equation t1/2 = VD / Cl * 0.693 was used | Primary Target and PDB code of Protein-Drug complex | Targets from DrugCentral | Links | |||
| NALOXONE
| NALOXONE |
VARIOUS | INJECTION ORAL SUBLINGUAL BUCCAL INTRAMUSCULAR SUBCUTANEOUS NASAL | Cmax 0.85 NANOMOLAR Tmax 0.81 HOUR VD 110.5 LITER (65 KILOGRAM) PPB 45 PERCENT Cl 89.7 LITER / HOUR (65 KILOGRAM) HT 6.25 HOUR SOLUBILITY SOLUBLE IN WATER | MU-TYPE OPIOID RECEPTOR PDB 9BJK (INACTIVE MU OPIOID RECEPTOR BOUND TO NB6, NALOXONE AND NAM) LIGAND CODE = A1APV (link to the list of PDB complexes) Download experimental 3D coordinates of A1APV with added hydrogens | Mu-type opioid receptor UNIPROT P35372 OPRM1 more at DrugCentral | EMA | |||
